Dr. Gary Kobinger: Developing Vaccines for Pandemics – Contrasting the Ebola and COVID-19 experience | La mise au point de vaccins pour lutter contre les pandémies : comparaison de l’expérience vécue avec le virus Ebola et le coronavirus
The current efforts to develop safe and protective vaccines against COVID-19 are unprecedented both in terms of speed and amount of data collected and shared. In response to COVID-19, the world could see the first vaccine to ever be licensed in a time period that may be only one year or so from the time of detection of the target pathogen. This presentation will highlight opportunities and challenges in therapeutic and vaccine research in Canada in the context of the COVID-19 pandemic.